CellupepTB-500
Ordered TB-500 from Cellupep? Mail in a sample (US only) and let us test it for free.
Test my supplyCellupep's TB-500 signal is mixed: purity swings from an early 89.9% miss to 99.7% passes, then a later 99.2% miss. The most recent tested vial also showed +28% overfill, making consistency the key caveat.
Corporate and domain records point to a recent, privacy-protected operation behind Cellupep’s manufacturer-style claims. The full report follows the COA gallery, UK/HK contact layer, European storefront, and mixed fulfillment trail without relying on vendor screenshots.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Cellupep rows.
Cancel anytime
About Cellupep test results from Finnrick
Cellupep is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 42 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Cellupep peptides in this dataset are BPC-157 (6 tests), GHK-Cu (5 tests) and Retatrutide (16 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 42 recent tests.
Ordered TB-500 from Cellupep? Mail in a sample (US only) and let us test it for free.
Test my supply